L. Hanker

Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes

L. Pusztai, C. Liedtke, T. Karn, 2012, Breast Cancer Research and Treatment.

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

B. Monk, A. Stuckey, Zangdong He, 2023, The New England journal of medicine.

Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)

J. Sehouli, D. Hornung, C. Marth, 2023, International Journal of Gynecological Cancer.

Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group

F. Marmé, J. Sehouli, F. Heitz, 2023, International Journal of Gynecological Cancer.

Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients

S. Perner, G. Gitas, F. Köster, 2023, Journal of cancer research and clinical oncology.

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

P. Fasching, C. Denkert, F. Marmé, 2021, BMC Cancer.

Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment

K. Shima, J. Rupp, M. Stadler, 2023, Antibiotics.

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

A. deFazio, B. Karlan, A. Berchuck, 2024, NPJ genomic medicine.